Brian Morris | Hypertension | Best Academic Researcher Award

Prof. Dr. Brian Morris | Hypertension | Best Academic Researcher Award

University Of Sydney | Australia

Professor Dr. Brian Morris is a highly respected biomedical scientist and Professor Emeritus at the School of Medical Sciences, University of Sydney, acclaimed for his groundbreaking research in molecular medical sciences, hypertension, and public health. Throughout his distinguished career, he has made substantial contributions to understanding the genetic and molecular foundations of cardiovascular disease and ageing. He has held several prominent academic positions, including Professor of Molecular Medical Sciences and Senior Lecturer in Physiology, and has provided influential leadership in organizing international scientific conferences, such as the first global meeting on the molecular genetics of hypertension. Professor Morris has also served on major national and international research committees, editorial boards, and review panels, and is recognized as an exceptional mentor whose students have gone on to achieve senior positions in academia and industry worldwide. His numerous honors and fellowships from prestigious organizations reflect his exceptional contributions to science and education. With a prolific publication record of 404 documents, his research has received 11,835 citations from 8,579 documents, achieving an h-index of 56. His studies, published in leading journals including Circulation, Nature Genetics, PNAS, and Hypertension, have influenced scientific thought globally. His pioneering patent for the first use of PCR in viral detection further underscores his lasting impact on molecular diagnostics. Through his scientific innovation, academic leadership, and lifelong dedication to advancing knowledge, Professor Morris has made enduring contributions to cardiovascular and molecular health research worldwide.

Profiles: Scopus | Orcid

Featured Publications

Sarman, G., Cox, G., & Morris, B. J. (2025). Critique of “The impact of foot reflexology on postoperative pain and fear in children following circumcision: A randomized controlled trial.” Journal of Pediatric Urology.

Cox, G., & Morris, B. J. (2025). Comments on Fendereski et al., Comparing penile problems in circumcised vs. uncircumcised boys: Insights from a large commercial claims database with a focus on provider type performing circumcision. Journal of Pediatric Surgery.

Chen, R., Donlon, T. A., Morris, B. J., Allsopp, R. C., Willcox, B. J., & Masaki, K. H. (2024). Association of alcohol with lung cancer risk in men with different growth hormone receptor genotypes. Lung Cancer.

Chen, R., Morris, B. J., Donlon, T. A., Nakagawa, K., Allsopp, R. C., Willcox, B. J., Masaki, K. H., & Lipsitz, L. A. (2024). FOXO3 longevity genotype mitigates risk posed by hypertension on incident coronary artery disease in middle-aged men: Kuakini Honolulu Heart Program. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.

Morris, B. J., & Banerjee, J. (2024). Comment on ‘Changing relationships between HIV prevalence and circumcision in Lesotho’, and ‘Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa’. Journal of Biosocial Science.

Morris, B. J., & Klausner, J. D. (2024). Detrimental to public health: Royal Australasian College of Physicians’ recent policy on infant circumcision. Pediatric Research.

Caicai Xi | Cardiovascular Researches | Best Researcher Award

Prof. Caicai Xi | Cardiovascular Researches | Best Researcher Award

Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University | China

Prof. Caicai Xi is a postdoctoral fellow at the College of Life Sciences, Zhejiang University, and holds a doctoral degree from Nanjing University of Chinese Medicine. Her research expertise lies in the total synthesis, extraction, separation, and biological evaluation of natural products derived from traditional Chinese medicine (TCM). She has also made significant contributions to the fields of production and synthetic biology of TCM resources, pharmacological and active material basis studies of TCM compound serum, and the development of hospital preparations and new drug formulations. Prof. Xi’s research aims to promote the rational utilization, modernization, and industrial application of TCM resources through scientific innovation and interdisciplinary integration. She has published 15 academic papers, which have collectively received 137 citations, and her work is reflected in an h-index of 3, indicating a growing academic impact in her area of specialization. Beyond her research publications, Prof. Xi has presided over and participated in 11 scientific research projects, contributed to the drafting of one technical standard, and co-authored one academic monograph. Recognized as a High-level Talent (Class E) in Zhejiang Province and Hangzhou City, she also holds positions in national professional organizations dedicated to TCM research and innovation. Her active participation in these scientific communities underscores her commitment to advancing the modernization and global relevance of traditional Chinese medicine through innovative research and collaborative development.

Profile: Scopus

Featured Publication

Wu, R., Wang, J., Zhou, H., Xue, X., Tong, C., Zhao, L., Wu, Y., Mei, X., Guo, Z., & Xi, C. (2025). Analysis of blood components and target prediction for the combined use of Dendrobium officinale compound and Western medicine in antihypertensive therapy based on network pharmacology and molecular docking. Drug Design, Development and Therapy